Dare Bioscience, Inc. — Director's Dealing 2016

Jun 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-06-22

Reporting Person: WALT DAVID R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-22	Stock Option (right to buy)	$2.08	A	20000	Acquired	2026-06-21	Common Stock (20000)	Direct

Footnotes

F1: This option was granted on June 22, 2016. The shares underlying such option vest in full on the earlier of June 22, 2017 or immediately prior to the Corporation's 2017 annual meeting of stockholders, subject to the reporting person's continued service as a director of the Corporation through such date.